1
|
Comparato F, Di Lisi D, Puglisi C, Portelli MC, Cannizzo N, Damerino G, Di Caccamo L, Ortello A, Galassi AR, Novo G. Analysis of myocardial function by deformation imaging in patients with transthyretin gene mutation. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Hereditary transthyretin (TTR) amyloidosis is a rare disease that can affect various organs. The early identification of cardiac involvement through echocardiography allows to corroborate the diagnosis and to start therapy at an early stage.
Purpose
The aim of our study was to detect early signs of cardiac involvement in patients with TTR gene mutation and neurological phenotype or absence of any organ disease (carriers) compared to patients with TTR gene mutation and cardiac amyloidosis (CA).
Material and methods
An observational study was conducted on a sample of 31 patients with TTR gene mutation. Patients were divided into 3 groups (23% CA, 42% amyloid neuropathy and 35% carriers). All patients underwent echocardiography with evaluation of left ventricular myocardial deformation indices (apical/basal strain ratio and relative apical sparing).
Results
Carriers and patients with amyloid neuropathy had normal left ventricular systolic and diastolic function. Analyzing left ventricular longitudinal global strain (GLS) we didn't find significant differences between carriers and neuropathy, but we found a significant difference about apical/basal strain ratio and relative apical sparing (respectively 1.33±0.20 vs 1.58±0.25, p value 0.001 and 0.62±0.07 vs 0.72±0.08, p value 0.039).
Conclusion
Relative apical sparing is specific to identify CA; the apical/basal ratio seems to gradually increase from carriers to patients with cardiac amyloidosis and it could be used to monitor patients with TTR mutation, before developing CA.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | - D Di Lisi
- University of Palermo , Palermo , Italy
| | - C Puglisi
- University of Palermo , Palermo , Italy
| | | | | | | | | | - A Ortello
- University of Palermo , Palermo , Italy
| | | | - G Novo
- University of Palermo , Palermo , Italy
| |
Collapse
|